SCHEMBL7736233

SCHEMBL7736233

N#C/C(=N\Nc1c(Cl)cc(C(F)(F)F)cc1Cl)c1ccc(C#N)cc1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAPGEF3 O95398 4/20 0.38
RAPGEF4 Q8WZA2 3/20 0.38
KDM4E B2RXH2 1/20 0.38
MAPT P10636 1/20 0.38
MAPK1 P28482 1/20 0.38
L3MBTL1 Q9Y468 1/20 0.38
KIF11 P52732 1/20 0.38
MRGPRX4 Q96LA9 3/20 0.37
GABRP O00591 1/20 0.35
GABRD O14764 1/20 0.35
GABRA1 P14867 1/20 0.35
GABRB1 P18505 1/20 0.35
GABRG2 P18507 1/20 0.35
GABRB3 P28472 1/20 0.35
GABRA5 P31644 1/20 0.35
GABRA3 P34903 1/20 0.35
GABRA2 P47869 1/20 0.35
GABRB2 P47870 1/20 0.35
GABRA4 P48169 1/20 0.35
GABRE P78334 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7736234 1.00 RAPGEF3 (0.38) RAPGEF3RAPGEF4KDM4EMAPTMAPK1
SCHEMBL7744122 0.90 NPSR1 (0.43) RAPGEF3RAPGEF4MAPTL3MBTL1NPSR1
SCHEMBL7744125 0.90 NPSR1 (0.43) RAPGEF3RAPGEF4MAPTL3MBTL1NPSR1
SCHEMBL7744112 0.86 KIF11 (0.39) RAPGEF3RAPGEF4KDM4EMAPTMAPK1
SCHEMBL7744114 0.86 KIF11 (0.39) RAPGEF3RAPGEF4KDM4EMAPTMAPK1
SCHEMBL7736249 0.83 DDR1 (0.40) RAPGEF3RAPGEF4KDM4EMAPTMAPK1
SCHEMBL8210068 0.82 MAPT (0.41) RAPGEF3RAPGEF4MAPTMAPK1KIF11
SCHEMBL8079598 0.82 NPSR1 (0.38) RAPGEF3RAPGEF4MAPTL3MBTL1NPSR1
SCHEMBL8210065 0.82 MAPT (0.41) RAPGEF3RAPGEF4MAPTMAPK1KIF11
SCHEMBL7736245 0.76 GABRP (0.36) RAPGEF3RAPGEF4KDM4EMAPTMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6417386-B2 HYDRAZONE DERIVATIVES; ACARINA; MITICIDES SYNGENTA CROP PROTECTION, INC. 2002-07-09 US disclosed
US-20010039247-A1 Pesticidal compositions KARRER FRIEDRICH (CH) 2001-11-08 US disclosed
US-6306798-B1 Compounds for controlling insects and representatives of the order acarina SYNGENTA CROP PROTECTION, INC. 2001-10-23 US disclosed
EP-1021398-A1 PESTICIDAL COMPOSITIONS Novartis AG (CH) 2000-07-26 EP disclosed
WO-1998003475-A1 PESTICIDAL COMPOSITIONS NOVARTIS AG (CH) 1998-01-29 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20010039247-A1 Pesticidal compositions MTX1, PEF1, ECH1 RAPGEF3 3566/4885RAPGEF4 3981/4885KDM4E 4178/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.